These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33820760)

  • 21. Sodium-glucose cotransporter 2 inhibition attenuates protein overload in renal proximal tubule via suppression of megalin O-GlcNacylation in progressive diabetic nephropathy.
    Otomo H; Nara M; Kato S; Shimizu T; Suganuma Y; Sato T; Morii T; Yamada Y; Fujita H
    Metabolism; 2020 Dec; 113():154405. PubMed ID: 33069809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.
    Shi Y; Lo CS; Chenier I; Maachi H; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1335-46. PubMed ID: 23552863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes.
    Miyata KN; Lo CS; Zhao S; Zhao XP; Chenier I; Yamashita M; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Diabetologia; 2021 Nov; 64(11):2589-2601. PubMed ID: 34370045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knockout of Na
    Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.
    Ghosh A; Abdo S; Zhao S; Wu CH; Shi Y; Lo CS; Chenier I; Alquier T; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Endocrinology; 2017 Apr; 158(4):903-919. PubMed ID: 28324005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of SGLT2 in the kidney of a P. gingivalis LPS-induced diabetic nephropathy mouse model.
    Kajiwara K; Sawa Y
    BMC Nephrol; 2021 Aug; 22(1):287. PubMed ID: 34425759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.
    Woods TC; Satou R; Miyata K; Katsurada A; Dugas CM; Klingenberg NC; Fonseca VA; Navar LG
    Am J Nephrol; 2019; 49(4):331-342. PubMed ID: 30921791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice.
    Miyata KN; Lo CS; Zhao S; Liao MC; Pang Y; Chang SY; Peng J; Kretzler M; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Clin Sci (Lond); 2021 Apr; 135(7):943-961. PubMed ID: 33822013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MDM2 controls NRF2 antioxidant activity in prevention of diabetic kidney disease.
    Guo W; Tian D; Jia Y; Huang W; Jiang M; Wang J; Sun W; Wu H
    Biochim Biophys Acta Mol Cell Res; 2018 Aug; 1865(8):1034-1045. PubMed ID: 29704532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium glucose cotransporter 2 and the diabetic kidney.
    Komala MG; Panchapakesan U; Pollock C; Mather A
    Curr Opin Nephrol Hypertens; 2013 Jan; 22(1):113-9. PubMed ID: 23042029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene deletion of the Na
    Nespoux J; Patel R; Hudkins KL; Huang W; Freeman B; Kim YC; Koepsell H; Alpers CE; Vallon V
    Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1201-F1210. PubMed ID: 30995111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.
    Aleksunes LM; Reisman SA; Yeager RL; Goedken MJ; Klaassen CD
    J Pharmacol Exp Ther; 2010 Apr; 333(1):140-51. PubMed ID: 20086057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium/glucose cotransporter 2 inhibitors and prevention of diabetic nephropathy: targeting the renal tubule in diabetes.
    De Nicola L; Gabbai FB; Liberti ME; Sagliocca A; Conte G; Minutolo R
    Am J Kidney Dis; 2014 Jul; 64(1):16-24. PubMed ID: 24673844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epoxyeicosatrienoic acids improve glucose homeostasis by preventing NF-κB-mediated transcription of SGLT2 in renal tubular epithelial cells.
    Fu M; Yu J; Chen Z; Tang Y; Dong R; Yang Y; Luo J; Hu S; Tu L; Xu X
    Mol Cell Endocrinol; 2021 Mar; 523():111149. PubMed ID: 33387601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of renal superoxide dismutase by telmisartan therapy in C57BL/6-Ins2(Akita) diabetic mice.
    Fujita H; Fujishima H; Morii T; Sakamoto T; Komatsu K; Hosoba M; Narita T; Takahashi K; Takahashi T; Yamada Y
    Hypertens Res; 2012 Feb; 35(2):213-20. PubMed ID: 22072110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.
    Al-Obaidi N; Mohan S; Liang S; Zhao Z; Nayak BK; Li B; Sriramarao P; Habib SL
    FASEB J; 2019 Jan; 33(1):373-387. PubMed ID: 29975570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene knockout of the Na
    Nespoux J; Patel R; Zhang H; Huang W; Freeman B; Sanders PW; Kim YC; Vallon V
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1100-F1112. PubMed ID: 32116018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced
    Hodrea J; Balogh DB; Hosszu A; Lenart L; Besztercei B; Koszegi S; Sparding N; Genovese F; Wagner LJ; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2020 Apr; 318(4):F1017-F1029. PubMed ID: 32116017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced NRF2 activation.
    Kim MN; Moon JH; Cho YM
    Diabetes Obes Metab; 2021 Nov; 23(11):2561-2571. PubMed ID: 34318973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.